Physician
Family Medicine
Dr. John L. Forsythe, MD
|
|
Give Review
John Forsythe works in the field of Family Medicine. John Forsythe is also a published physician. He has 81 publication published. The most recent publication is: The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection.
Publications
- Patient consent for blood transfusion--recommendations from SaBTO.
- A New UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys.
- Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy.
- Advisory committee on the safety of blood, tissues and organs.
- An overview of transplantation in culturally diverse regions.
- Variations in the assessment practice for renal transplantation across the United Kingdom.
- Commercially available recombinant sonic hedgehog up-regulates Ptc and modulates the cytokine and chemokine expression of human macrophages: an effect mediated by endo...
- The use of marginal heart beating donor livers for transplantation in the United kingdom.
- Gender disparities in live kidney donation: fundamental moral differences?
- Renal transplantation in the United Kingdom for patients from ethnic minorities.
- Uncovering a rare but critical complication following thyroid surgery: an audit across the UK and Ireland.
- Are men really wimps?
- "Dirty little secrets"--endotoxin contamination of recombinant proteins.
- The assembly line approach in kidney transplantation--back to the future?
- Which index is optimal for assessment of baseline comorbidities in kidney transplant recipients?
- Higher quality of life in living donor kidney transplantation: prospective cohort study.
- Impact of cadaveric renal transplantation on survival in patients listed for transplantation.
- The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid.
- How old is old for transplantation?
- Management of biliary tract complications after orthotopic liver transplantation.
- The role of vascular endothelial growth factor in the kidney in health and disease.
- How great is the survival advantage of transplantation over dialysis in elderly patients?
- Human leukocyte antigen and the allocation of kidneys from cadaver donors in the United Kingdom.
- Incentives to promote organ donation.
- Equity of access to renal transplant waiting list and renal transplantation in Scotland: cohort study.
- To biopsy or not to biopsy.
- Insurance issues in living kidney donation.
- Establishing a transplant coordinator-led living kidney donor follow-up clinic.
- Ethical market in organs. Defending the indefensible?
- Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
- Does a kidney-sharing alliance have to sacrifice cold ischemic time for better HLA matching?
- How can we improve organ donation rates? Research into the identification of factors which may influence the variation.
- Graft function and other risk factors as predictors of cardiovascular disease outcome.
- Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients.
- Adaptation of a weight management program for a potential lung transplant candidate.
- Training opportunities in liver transplantation surgery.
- Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
- Kidney damage during organ retrieval: data from UK National Transplant Database. Kidney Advisory Group.
- The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection.
- Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
- Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
- Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicen...
- Thrombotic occlusion of ureteric stent: an unusual cause of anuria after kidney transplantation.
- Flow cytometric crossmatching in renal transplantation--the long-term outcome.
- Reversal of steroid-resistant rejection in renal allograft recipients using FK506.
- Diabetic matching in renal transplantation.
- Kidney retrieval from asystolic donors: a valuable and viable source of additional organs.
- The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients.
- Urologic complications after renal transplantation: a prospective randomized trial comparing different techniques of ureteric anastomosis and the use of prophylactic u...
- Successful renal transplantation with a positive T-cell cross match caused by IgM antibodies.
- Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody.
- Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1.
- Developing the ideal immunosuppressive protocol by internal audit.
- Cultured endothelium. Heparin antagonizes the induction of class II MHC molecules by interferon-gamma.
- The paradox of ATG monitoring in renal transplantation.
- Treatment of right hepatic artery injury by percutaneous embolisation.
- Xenotransplantation: an examination of the adhesive interactions between human lymphocytes and porcine renal epithelial cells.
- Xenotransplantation: adhesive interactions between porcine renal cells and human lymphocytes.
- Adhesion molecule blockade in a porcine xenograft model.
- ATG--a polyclonal sledgehammer?
- Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantation.
- Value of flow cytometric monitoring of posttransplant antibody status in renal transplantation.
- Renal allograft rejection: examination of adhesion blockade by antilymphocyte antibody drugs.
- Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection.
- Sensitive monitoring of polyclonal antilymphocyte agents in renal transplantation.
- Renal allograft rejection: induction and function of adhesion molecules on cultured epithelial cells.
- Surgical aspects of chronic peritoneal dialysis in the neonate and infant under 1 year of age.
- Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection.
- Hemostasis at the time of renal transplantation for bleeding following core biopsy.
- Renal allograft rejection. Possible involvement of antibody-dependent cell-mediated cytotoxicity.
- Late perfusion. A simple remedy for renal allograft primary nonfunction.
- The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation.
- Renal replacement treatment in patients with spina bifida or spinal cord injury.
- Renal carcinoma with adjacent retroperitoneal fibrosis.
- Reducing renal injury during transplantation.
- Plasma interleukin 2 receptor levels in renal allograft dysfunction.
- Renal allograft rejection: possible involvement of lymphokine-activated killer cells.
- Renal allograft rejection: protection of renal tubular epithelial cells from lymphokine activated killer cell mediated lysis by pretreatment with cytokines.
- Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
- Coronal sonography: a review of abdominal applications.
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- HealthSmart
- Choice Care PPO
- Preferred PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- NGS CoreSource
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Drug Facts
| NPI NUMBER | 1326047457 | |
| NPPES Provider LastName | FORSYTHE | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 776427543 | |
| NPPES Provider State | TX | |
| Specialty Description | Family Practice | |
| Total Claim Count | 7703.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 520.0 | |
| Percent Opioid Claims | 6.75 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326047457 |
| Last Name Of The Provider | FORSYTHE |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Avila E. Arcala, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Hanh M. Nguyen, PA
This Doctor is OpenDoctor Recommended.
|
|
Dr. Colin L. Hales, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Austin C. Walkes, MD |
|
|
Dr. David L. Sawisky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracie D. Updike, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hong C. Trinh, MD
This Doctor is OpenDoctor Recommended.
|